Navigation Links
Persistent Insomnia Leads to Depression in Young Adults
Date:4/2/2008

When it lasts 2 weeks or more, it predicts major episodes, study finds

WEDNESDAY, April 2 (HealthDay News) -- Persistent bouts of insomnia in young adults can increase their risk of developing depression, says a new report.

A long-term study of almost 600 young adults found that those with annual one-month periods of insomnia found the incidents of sleeplessness gradually increased over two decades, especially among women. In 40 percent of subjects, insomnia developed into more chronic forms over time, according to findings published in the April 1 issue of Sleep.

Insomnia lasting two weeks or longer predicted major depressive episodes and disorders, according to the report. Seventeen percent to 50 percent of subjects with insomnia lasting two weeks or longer later developed a major depressive episode.

"The results show that insomnia seems to be followed by depression more consistently than the other way around. In addition, we found that insomnia tended to be a chronic problem that gets more persistent over time, whereas depression was a more intermittent problem," study author Dr. Daniel J. Buysse, of the University of Pittsburgh, said in a prepared statement.

The study, conducted by Dr. Jules Angst, of Zurich University Psychiatric Hospital in Switzerland, focused on 591 young adults, whose psychiatric, physical and sleep symptoms were assessed with six interviews spanning 20 years.

"We used to think that insomnia was most often just a symptom of depression. However, a growing body of evidence suggests that insomnia is not just a symptom of depression, but that it may actually precede depression. In other words, people who have insomnia but no depression are at increased risk for later developing depression," Buysee said.

Insomnia, the most common of all sleep disorders, is when a person has trouble falling asleep, staying asleep or waking up too early. About 30 percent of ad
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Study Analyzed Long-Term SYMBICORT(R) Use in Children With Persistent Asthma
2. Study identifies which men are likely to have persistent prostate cancer
3. Want to Raise a Fruit-and-Veggie Lover? Be Persistent
4. Meniscal damage and the development of persistent knee pain
5. Comment Regarding Congregation for the Doctrine of Faith Clarification Concerning Nutrition and Hydration for Patients in a Persistent Vegetative State
6. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
7. Adolescents with chronic insomnia report twofold to fivefold increase in personal problems
8. Insomnia patients often denied sleep treatment when they have mental health conditions
9. Ambien CR(R) (zolpidem tartrate extended-release) tablets CIV Improved Chronic Insomnia in Patients with Co-Morbid Generalized Anxiety Disorder
10. Journal Sleep: A short-term dose of zolpidem is an effective treatment for insomnia
11. Insomniac Fish May Help Sleepless People

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Persistent Insomnia Leads to Depression in Young Adults
Persistent Insomnia Leads to Depression in Young Adults
(Date:11/27/2009)...ER, N.Y., Nov. 27 Preve...vider and fortunately every year, new vaccines are...do all vaccines boost immunity for the same period...r shots, needed to keep immunity strong? ,, I... the American Academy of Pediatrics, Michael Pichi...
(Date:11/27/2009)... XenaCare Holdings has announced that it has...tion, one of the largest nonprofit organizations d...ducation. , Delray Beach,..., Inc. (OTCBB: XCHO), a company specializing in th...althcare products, has announced today that is has...
(Date:11/27/2009)... , SEATTLE, Nov. 27 Allreci...ord-high Thanksgiving traffic numbers, with more t...ng, providing a clear picture of what was served o...e Thanksgiving meal in 2009 weighed in at 2,225 ca... year,s feast. According to the Allrecipes site, ...
(Date:11/27/2009)... Specialist manufacturers who use medical lo... millions of dollars by bringing in technology par...ng numbers of pro-active medical manufacturers are...pt stage of their projects, ensuring that progress...ses or potentially outdated technology. , ...
(Date:11/26/2009)...ETON, N.J., Nov. 27 The diabetes p...over the next 25 years and annual medical spending...up from $113 billion today, according to a study p... The National Changing Diabetes ® Program (... analysis by a team from the University of Chicago...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4
...an,orthopedic implants company focused on silicon ... Ashok Khandkar, Ph.D., Chief Executive,Officer, a...f Financial,Officer, are scheduled to present at t...Khandkar and Mr. Gallacher will provide a general ...
...A preparation with no,detectable large RNA and fur... developing area of RNAi, ST....s pleased to introduce mirPremier(TM) microRNA Iso...,purifying and enriching miRNA along with other sm...
...ed those with Lou Gehrig,s disease , , THU...ntibiotic minocycline against amyotrophic lateral ...ed because patients taking the drug had a signific...s such as multiple sclerosis, said a report publis...
...aloon will,host a tribute to the late songwriter W...PM to raise research money and awareness for Mesot...much loved and respected troubadour.,Tickets for t...ds from the show will go to The Mesothelioma Appli...
...anxiety from stressful life situations may be more...ast the first six months after the event, accordin...the journal SLEEP. , The study, authored by Jussi...urbed sleep and 2,572 with disturbed sleep, all of...
...,unveil the successor to its unique Xcelodose syst...and vials at the American Association of,Pharmaceu...o (November 11th,-15th, 2007). The new Xcelodose ...nded software functionality. These enhancements w...
Other Medicine News:Health News:Sigma-Aldrich Announces mirPremier(TM) microRNA Isolation Kit for miRNA Purification 2Health News:Sigma-Aldrich Announces mirPremier(TM) microRNA Isolation Kit for miRNA Purification 3Health News:Study Shows Antibiotic Harms ALS Patients 2Health News:Friends of Warren Zevon To Play at Maverick Saloon - Raising Awareness of Asbestos Cancer, Mesothelioma 2Health News:Anxiety linked to sleep disturbances 2Health News:New Generation Xcelodose(R)S Precision Drug Powder Micro-filling System Offers 50% Increased Throughput 2
(Date:11/25/2009)..., NEW YORK, Nov. 25 Reportlinker...s available in its catalogue: ,, Intranasal Dr...tp://www.reportlinker.com/p0164267/Intranasal-Drug... The US intranasal drug delivery market is witness...the delivery of conventional local therapeutic dru...
(Date:11/25/2009)...NTAIN VIEW, Calif., Nov. 25 Chem...clinical data from the Company,s PROTECT-1 (the Pr...ohn,s disease Trial) of Traficet-EN(TM) (CCX282-B)...se demonstrated clinical efficacy with a favorable...strated evidence of clinical efficacy in the reduc...
(Date:11/24/2009)...VINE, Calif., Nov. 24 En...ally invasive treatments for aortic disorders, ann...r discontinue all proceedings in, the patent infri... by Cook, Inc. The motion was filed in the United..., Endologix has requested that the stay remain ...
Breaking Medicine Technology:Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR NCI EORTC MEETING 14904 1YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR NCI EORTC MEETING 14904 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR NCI EORTC MEETING 14904 3BeamOne LLC to Add New Ebeam Sterilization Service Center 6384 1BeamOne LLC to Add New Ebeam Sterilization Service Center 6384 2Residential design for persons with neurological disability 61642 1Residential design for persons with neurological disability 61642 2Residential design for persons with neurological disability 61642 3
...es,Pharmaceuticals, Inc., (Nasdaq: ALSE ), announ...n the initial stage of the ALTROPANE(R) Parkinson,...cal trial program. This,subject was enrolled at th...er the direction of Principal Investigator Dr. Ray...ment of Neurology., ALTROPANE is a diagnostic mol...
...(TM) shows lifesaving potential -, - HGS on trac...ockpile beginning in 2008...s, Inc. (Nasdaq: HGSI ) today announced that the ...e-saving potential of its human,monoclonal antibod... that a,single dose of ABthrax, administered witho...
Other Medicine Technology:Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 2Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 3Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 4Alseres Pharmaceuticals Initiates the ALTROPANE(R) POET-2 Phase III Clinical Trial Program 5New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 2New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 3New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 4New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 5New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 6New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies 7
Lasik Irrigator - 4 ports
Lasik Cannula - Rosen
Anterior Chamber Maintainer
Sub-Tenon's Cannula
Medicine Products: